{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:04:00Z","timestamp":1785780240021,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.diagmicrobio.2021.115480","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T13:32:39Z","timestamp":1625751159000},"page":"115480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment and utility of 2 Chlamydia trachomatis Pgp3 serological assays for seroprevalence studies among women in the United States"],"prefix":"10.1016","volume":"101","author":[{"given":"Damien C.","family":"Danavall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gwyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria E.","family":"Anyalechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Kirkcaldy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen N.","family":"Kersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.diagmicrobio.2021.115480_bib0001","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3201\/eid2407.171928","article-title":"Integrated serologic surveillance of population immunity and disease transmission","volume":"24","author":"Arnold","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115480_bib0003","unstructured":"Centers for Disease Control and Prevention - National Center for Health Statistics. National Health and Nutrition Examination Survey. Available at: https:\/\/www.cdc.gov\/nchs\/nhanes\/index.htm. Accessed November 3, 2020."},{"issue":"13","key":"10.1016\/j.diagmicrobio.2021.115480_bib0004","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1177\/0956462418785244","article-title":"Comparison of three serological assays to measure antibody response to Chlamydia antigen Pgp3 in adolescent and young adults with pelvic inflammatory disease","volume":"29","author":"Dize","year":"2018","journal-title":"Int J STD AIDS"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2021.115480_bib0005","doi-asserted-by":"crossref","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","article-title":"CT694 and pgp3 as serological tools for monitoring trachoma programs","volume":"6","author":"Goodhew","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2021.115480_bib0006","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4269\/ajtmh.17-0292","article-title":"Comparison of platforms for testing antibody responses against the Chlamydia trachomatis antigen Pgp3","volume":"97","author":"Gwyn","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2021.115480_bib0007","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2021.115480_bib0008","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/microorganisms7100442","article-title":"Antibody testing in estimating past exposure to Chlamydia trachomatis in the Netherlands chlamydia cohort study","volume":"7","author":"Hoenderboom","year":"2019","journal-title":"Microorganisms."},{"issue":"5","key":"10.1016\/j.diagmicrobio.2021.115480_bib0009","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/sextrans-2011-050386","article-title":"Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study","volume":"89","author":"Horner","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2021.115480_bib0010","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1128\/IAI.02576-14","article-title":"Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice","volume":"82","author":"Liu","year":"2014","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2021.115480_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008316","article-title":"The use of serology for trachoma surveillance: current status and priorities for future investigation","volume":"14","author":"Martin","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2021.115480_bib0012","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4269\/ajtmh.20-0777","article-title":"Population-based prevalence of Chlamydia trachomatis infection and antibodies in four districts with varying levels of trachoma endemicity in amhara, ethiopia","volume":"104","author":"Nash","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.diagmicrobio.2021.115480_bib0013","doi-asserted-by":"crossref","first-page":"c1642","DOI":"10.1136\/bmj.c1642","article-title":"Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial","volume":"340","author":"Oakeshott","year":"2010","journal-title":"BMJ"},{"issue":"RR-02","key":"10.1016\/j.diagmicrobio.2021.115480_bib0014","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20132014","volume":"63","author":"Papp","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2021.115480_bib0015","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1038\/s41467-018-07852-0","article-title":"The utility of serology for elimination surveillance of trachoma","volume":"9","author":"Pinsent","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.diagmicrobio.2021.115480_bib0016","series-title":"R: a language and environment for statistical computing. R Foundation for Statistical Computing","year":"2019"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2021.115480_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007027","article-title":"Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem","volume":"12","author":"Senyonjo","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2021.115480_bib0019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westr\u00f6m","year":"1992","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115480_bib0020","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2021.115480_bib0021","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/CVI.00021-09","article-title":"Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection","volume":"16","author":"Wills","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2021.115480_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152810","article-title":"Chlamydia trachomatis Pgp3 antibody population seroprevalence before and during an era of widespread opportunistic Chlamydia screening in England (1994-2012)","volume":"12","author":"Woodhall","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2021.115480_bib0023","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1016\/S1473-3099(18)30159-2","article-title":"Advancing the public health applications of Chlamydia trachomatis serology","volume":"18","author":"Woodhall","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321001735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321001735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:56:57Z","timestamp":1760003817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889321001735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0732889321001735"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115480","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment and utility of 2 Chlamydia trachomatis Pgp3 serological assays for seroprevalence studies among women in the United States","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115480"}}